Poster Presentations

Start Date

20-5-2014 12:30 PM

Description

Photodynamic therapy (PDT) is a combination of light and photosensitizing drug in which a photosensitizer is injected intravenously and accumulates in the tissue. This tissue is then irradiated by light at an appropriate wavelength and the drug leads to cytotoxicity with a cascade of biochemical responses which affects and inactivates the cancer cells in the tumor tissue. In the cells, PDT generally induces mitochondrial damage and apoptosis which destroy the tissue and induce an antitumor activity upon illumination. Benzoporphyrin-derivative verteporfin (BPD) and curcumin are two photosensitizer drugs having the capability in use of PDT. The therapeutic potential of BPD and curcumin as photosensitizers is limited by their low aqueous solubility and applicability. In this study, it is aimed to increase the bioavailability of these drugs to induce antitumor activity in the tumor cells. Liposomes and PLGA-based polymeric nanoparticles (PLGA NPs) are used as the drug carrier nanoparticles which have been considered as perfect carriers for cancer therapeutics and they are remarkably used in cancer therapy. BPD and curcumin-loaded liposomes and PLGA NPs were synthesized and characterized in terms of size, zeta potential, drug encapsulation efficiency and morphology. These nanoparticles were targeted towards breast cancer cell line (MDA-MB-231) in vitro MTS cytotoxicity assays and imaging.

Comments

Abstract of poster presented at the 2014 UMass Center for Clinical and Translational Science Research Retreat, held on May 20, 2014 at the University of Massachusetts Medical School, Worcester, Mass.

Creative Commons License

Creative Commons Attribution-Noncommercial-Share Alike 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.

Share

COinS
 
May 20th, 12:30 PM

Targeted Destruction of Triple Negative Breast Cancer using Nanoparticles

Photodynamic therapy (PDT) is a combination of light and photosensitizing drug in which a photosensitizer is injected intravenously and accumulates in the tissue. This tissue is then irradiated by light at an appropriate wavelength and the drug leads to cytotoxicity with a cascade of biochemical responses which affects and inactivates the cancer cells in the tumor tissue. In the cells, PDT generally induces mitochondrial damage and apoptosis which destroy the tissue and induce an antitumor activity upon illumination. Benzoporphyrin-derivative verteporfin (BPD) and curcumin are two photosensitizer drugs having the capability in use of PDT. The therapeutic potential of BPD and curcumin as photosensitizers is limited by their low aqueous solubility and applicability. In this study, it is aimed to increase the bioavailability of these drugs to induce antitumor activity in the tumor cells. Liposomes and PLGA-based polymeric nanoparticles (PLGA NPs) are used as the drug carrier nanoparticles which have been considered as perfect carriers for cancer therapeutics and they are remarkably used in cancer therapy. BPD and curcumin-loaded liposomes and PLGA NPs were synthesized and characterized in terms of size, zeta potential, drug encapsulation efficiency and morphology. These nanoparticles were targeted towards breast cancer cell line (MDA-MB-231) in vitro MTS cytotoxicity assays and imaging.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.